Correlation Between Denali Therapeutics and Dynavax Technologies
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Dynavax Technologies, you can compare the effects of market volatilities on Denali Therapeutics and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Dynavax Technologies.
Diversification Opportunities for Denali Therapeutics and Dynavax Technologies
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Denali and Dynavax is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Dynavax Technologies go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Dynavax Technologies
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Dynavax Technologies. In addition to that, Denali Therapeutics is 1.94 times more volatile than Dynavax Technologies. It trades about -0.03 of its total potential returns per unit of risk. Dynavax Technologies is currently generating about 0.09 per unit of volatility. If you would invest 1,178 in Dynavax Technologies on November 1, 2024 and sell it today you would earn a total of 135.00 from holding Dynavax Technologies or generate 11.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Dynavax Technologies
Performance |
| Timeline |
| Denali Therapeutics |
| Dynavax Technologies |
Denali Therapeutics and Dynavax Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Dynavax Technologies
The main advantage of trading using opposite Denali Therapeutics and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |